 | • レポートコード：QYR9ST06274 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、レゴラフェニブの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ボトル包装、フィルムコーティング包装に、用途別には、転移性結腸直腸癌、進行性消化管間質腫瘍、進行性肝細胞癌、その他にセグメント区分し、レゴラフェニブの世界市場を分析しました。 ・エグゼクティブ・サマリー ・レゴラフェニブの世界市場概要 ・レゴラフェニブの製造コスト構成分析 ・レゴラフェニブの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・レゴラフェニブの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・レゴラフェニブのセグメント分析（種類別） （ボトル包装、フィルムコーティング包装） ・レゴラフェニブのセグメント分析（用途別） （転移性結腸直腸癌、進行性消化管間質腫瘍、進行性肝細胞癌、その他） ・レゴラフェニブの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Bayer Pharmaceuticals、Beacon Pharmaceuticals、Drug International） ・レゴラフェニブの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Regorafenib market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Regorafenib volume and value at global level, regional level and company level. From a global perspective, this report represents overall Regorafenib market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Regorafenib in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Regorafenib manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Bayer Pharmaceuticals
Beacon Pharmaceuticals
Drug International
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Bottled Packaging
Film Coated Packaging
Segment by Application
Metastatic Colorectal Cancer
Advanced Gastrointestinal Stromal Tumours
Advanced Hepatocellular Carcinoma
Other
Table of Contents
Executive Summary
1 Industry Overview of Regorafenib
1.1 Definition of Regorafenib
1.2 Regorafenib Segment by Type
1.2.1 Global Regorafenib Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Bottled Packaging
1.2.3 Film Coated Packaging
1.3 Regorafenib Segment by Applications
1.3.1 Global Regorafenib Consumption Comparison by Applications (2014-2025)
1.3.2 Metastatic Colorectal Cancer
1.3.3 Advanced Gastrointestinal Stromal Tumours
1.3.4 Advanced Hepatocellular Carcinoma
1.3.5 Other
1.4 Global Regorafenib Overall Market
1.4.1 Global Regorafenib Revenue (2014-2025)
1.4.2 Global Regorafenib Production (2014-2025)
1.4.3 North America Regorafenib Status and Prospect (2014-2025)
1.4.4 Europe Regorafenib Status and Prospect (2014-2025)
1.4.5 China Regorafenib Status and Prospect (2014-2025)
1.4.6 Japan Regorafenib Status and Prospect (2014-2025)
1.4.7 Southeast Asia Regorafenib Status and Prospect (2014-2025)
1.4.8 India Regorafenib Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Regorafenib
2.3 Manufacturing Process Analysis of Regorafenib
2.4 Industry Chain Structure of Regorafenib
3 Development and Manufacturing Plants Analysis of Regorafenib
3.1 Capacity and Commercial Production Date
3.2 Global Regorafenib Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Regorafenib
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Regorafenib Production and Capacity Analysis
4.2 Regorafenib Revenue Analysis
4.3 Regorafenib Price Analysis
4.4 Market Concentration Degree
5 Regorafenib Regional Market Analysis
5.1 Regorafenib Production by Regions
5.1.1 Global Regorafenib Production by Regions
5.1.2 Global Regorafenib Revenue by Regions
5.2 Regorafenib Consumption by Regions
5.3 North America Regorafenib Market Analysis
5.3.1 North America Regorafenib Production
5.3.2 North America Regorafenib Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Regorafenib Import and Export
5.4 Europe Regorafenib Market Analysis
5.4.1 Europe Regorafenib Production
5.4.2 Europe Regorafenib Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Regorafenib Import and Export
5.5 China Regorafenib Market Analysis
5.5.1 China Regorafenib Production
5.5.2 China Regorafenib Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Regorafenib Import and Export
5.6 Japan Regorafenib Market Analysis
5.6.1 Japan Regorafenib Production
5.6.2 Japan Regorafenib Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Regorafenib Import and Export
5.7 Southeast Asia Regorafenib Market Analysis
5.7.1 Southeast Asia Regorafenib Production
5.7.2 Southeast Asia Regorafenib Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Regorafenib Import and Export
5.8 India Regorafenib Market Analysis
5.8.1 India Regorafenib Production
5.8.2 India Regorafenib Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Regorafenib Import and Export
6 Regorafenib Segment Market Analysis (by Type)
6.1 Global Regorafenib Production by Type
6.2 Global Regorafenib Revenue by Type
6.3 Regorafenib Price by Type
7 Regorafenib Segment Market Analysis (by Application)
7.1 Global Regorafenib Consumption by Application
7.2 Global Regorafenib Consumption Market Share by Application (2014-2019)
8 Regorafenib Major Manufacturers Analysis
8.1 Bayer Pharmaceuticals
8.1.1 Bayer Pharmaceuticals Regorafenib Production Sites and Area Served
8.1.2 Bayer Pharmaceuticals Product Introduction, Application and Specification
8.1.3 Bayer Pharmaceuticals Regorafenib Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Beacon Pharmaceuticals
8.2.1 Beacon Pharmaceuticals Regorafenib Production Sites and Area Served
8.2.2 Beacon Pharmaceuticals Product Introduction, Application and Specification
8.2.3 Beacon Pharmaceuticals Regorafenib Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Drug International
8.3.1 Drug International Regorafenib Production Sites and Area Served
8.3.2 Drug International Product Introduction, Application and Specification
8.3.3 Drug International Regorafenib Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
9 Development Trend of Analysis of Regorafenib Market
9.1 Global Regorafenib Market Trend Analysis
9.1.1 Global Regorafenib Market Size (Volume and Value) Forecast 2019-2025
9.2 Regorafenib Regional Market Trend
9.2.1 North America Regorafenib Forecast 2019-2025
9.2.2 Europe Regorafenib Forecast 2019-2025
9.2.3 China Regorafenib Forecast 2019-2025
9.2.4 Japan Regorafenib Forecast 2019-2025
9.2.5 Southeast Asia Regorafenib Forecast 2019-2025
9.2.6 India Regorafenib Forecast 2019-2025
9.3 Regorafenib Market Trend (Product Type)
9.4 Regorafenib Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Regorafenib Distributors List
10.3 Regorafenib Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Regorafenib
Table Global Regorafenib Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Regorafenib Production Market Share by Types in 2018
Figure Bottled Packaging Product Picture
Figure Film Coated Packaging Product Picture
Table Global Regorafenib Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Regorafenib Consumption Market Share by Applications in 2018
Figure Metastatic Colorectal Cancer
Figure Advanced Gastrointestinal Stromal Tumours
Figure Advanced Hepatocellular Carcinoma
Figure Other
Figure Global Regorafenib Revenue (Million USD) (2014-2025)
Figure Global Regorafenib Production (K Pcs) (2014-2025)
Figure North America Regorafenib Market Size (Million USD) (2014-2025)
Figure Europe Regorafenib Market Size (Million USD) (2014-2025)
Figure China Regorafenib Market Size (Million USD) (2014-2025)
Figure Japan Regorafenib Market Size (Million USD) (2014-2025)
Figure Southeast Asia Regorafenib Market Size (Million USD) (2014-2025)
Figure India Regorafenib Market Size (Million USD) (2014-2025)
Table Regorafenib Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Regorafenib in 2018
Figure Manufacturing Process Analysis of Regorafenib
Figure Industry Chain Structure of Regorafenib
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Regorafenib Manufacturing Plants Distribution
Table Regorafenib Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Regorafenib Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Regorafenib Production (K Pcs) of Major Manufacturers (2014-2019)
Table Regorafenib Production Market Share of Major Manufacturers (2014-2019)
Figure Regorafenib Production Share by Manufacturers in 2018
Table Regorafenib Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Regorafenib Revenue Market Share of Major Manufacturers (2014-2019)
Figure Regorafenib Revenue Share by Manufacturers in 2018
Table Regorafenib Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Regorafenib Production by Regions 2014-2019 (K Pcs)
Table Global Regorafenib Production Market Share by Regions 2014-2019
Figure Global Regorafenib Production Market Share by Regions in 2018
Table Global Regorafenib Revenue by Regions 2014-2019 (Million USD)
Table Global Regorafenib Revenue Market Share by Regions 2014-2019
Figure Global Regorafenib Revenue Market Share by Regions in 2018
Table Global Regorafenib Consumption by Regions 2014-2019 (K Pcs)
Table Global Regorafenib Consumption Market Share by Regions 2014-2019
Figure North America Regorafenib Production Growth Rate 2014-2019 (K Pcs)
Figure North America Regorafenib Revenue Growth Rate 2014-2019 (Million USD)
Table North America Regorafenib Production, Consumption Import and Export (K Pcs)
Figure Europe Regorafenib Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Regorafenib Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Regorafenib Production, Consumption Import and Export (K Pcs)
Figure China Regorafenib Production Growth Rate 2014-2019 (K Pcs)
Figure China Regorafenib Revenue Growth Rate 2014-2019 (Million USD)
Table China Regorafenib Production, Consumption Import and Export (K Pcs)
Figure Japan Regorafenib Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Regorafenib Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Regorafenib Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Regorafenib Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Regorafenib Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Regorafenib Production, Consumption Import and Export (K Pcs)
Figure India Regorafenib Production Growth Rate 2014-2019 (K Pcs)
Figure India Regorafenib Revenue Growth Rate 2014-2019 (Million USD)
Table India Regorafenib Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Regorafenib Market Share by Application (2014-2019)
Figure Global Value (Consumption) Regorafenib Market Share by Application (2014-2019)
Table Bayer Pharmaceuticals Regorafenib Production Sites and Area Served
Table Bayer Pharmaceuticals Regorafenib Product Introduction, Application and Specification
Table Bayer Pharmaceuticals Regorafenib Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer Pharmaceuticals Regorafenib Production Growth Rate (2014-2019)
Table Bayer Pharmaceuticals Regorafenib Production Market Share (2014-2019)
Figure Bayer Pharmaceuticals Regorafenib Revenue Market Share (2014-2019)
Table Bayer Pharmaceuticals Regorafenib Main Business and Markets Served
Table Beacon Pharmaceuticals Regorafenib Production Sites and Area Served
Table Beacon Pharmaceuticals Regorafenib Product Introduction, Application and Specification
Table Beacon Pharmaceuticals Regorafenib Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Beacon Pharmaceuticals Regorafenib Production Growth Rate (2014-2019)
Table Beacon Pharmaceuticals Regorafenib Production Market Share (2014-2019)
Figure Beacon Pharmaceuticals Regorafenib Revenue Market Share (2014-2019)
Table Beacon Pharmaceuticals Regorafenib Main Business and Markets Served
Table Drug International Regorafenib Production Sites and Area Served
Table Drug International Regorafenib Product Introduction, Application and Specification
Table Drug International Regorafenib Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Drug International Regorafenib Production Growth Rate (2014-2019)
Table Drug International Regorafenib Production Market Share (2014-2019)
Figure Drug International Regorafenib Revenue Market Share (2014-2019)
Table Drug International Regorafenib Main Business and Markets Served
Figure Global Regorafenib Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Regorafenib Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Regorafenib Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Regorafenib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Regorafenib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Regorafenib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Regorafenib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Regorafenib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Regorafenib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Regorafenib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Regorafenib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Regorafenib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Regorafenib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Regorafenib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Regorafenib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Regorafenib by Type (2019-2025)
Table Global Consumption (K Pcs) of Regorafenib by Application (2019-2025)
Table Regorafenib Distributors List
Table Regorafenib Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
消化管間質腫瘍の世界市場：市場規模・現状・予測 Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract.Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as patho…- 消化管間質腫瘍（GIST）治療の世界市場：市場規模・現状・予測 A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine.In 2018, the global Gastrointestinal Stromal Tumors (GISTs) Treatment market size was xx million US$ and it is expected to reach xx million US$ by…
- 世界の高度包装システム市場：専門的調査 During the final stages of semiconductor development, a tiny block of materials (the silicon wafer, logic, and memory) is wrapped in a supporting case that prevents physical damage and corrosion and allows the chip to be connected to a circuit board. Typical packaging configurations have included th…
- 転移癌治療の世界市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
- 体外大腸癌スクリーニング検査の世界市場：市場規模・現状・予測 In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.Growing incidences of colon and rectal cancer and the introduction of novel screening tests employing genetic testing are the major factors expected to drive the in-vitro colorectal can…